Research Papers
All research highlights
Experimental model
Virus-host interaction
Published by
Eike Steinmann
Hepatitis E virus (HEV) primarily causes liver infections, but emerging evidence suggests that it can also affect other organs, including the nervous system, leading to a range of neurological disorde...
Hepatitis E virus (HEV) primarily causes liver infections, but emerging evidence suggests that it can also affect other organs, including the nervous system, leading to a range of neurological disorde...
Virology
Virus-host interaction
Published by
Wenshi Wang, Siddharth Sridhar
Hepatitis E virus (HEV) is the most common cause of viral hepatitis worldwide, with estimated 20 million infections and around 60,000 fatalities annually. Distinct from all the other human hepatitis v...
Hepatitis E virus (HEV) is the most common cause of viral hepatitis worldwide, with estimated 20 million infections and around 60,000 fatalities annually. Distinct from all the other human hepatitis v...
Clinical feature
Immunity
Published by
Yijin Wang
Organ transplant recipients with hepatitis E virus (HEV) infection bears high risk to develop chronic hepatitis, which is generally associated with immunosuppressive therapies. A research group led by...
Organ transplant recipients with hepatitis E virus (HEV) infection bears high risk to develop chronic hepatitis, which is generally associated with immunosuppressive therapies. A research group led by...
Clinical feature
Public health
Published by
FLORENCE ABRAVANEL
The major strains infecting humans are classified into 4 major genotypes with 2 distinct epidemiological profiles. In countries with poor environmental sanitation, HEV-1 and 2 (found exclusively in hu...
The major strains infecting humans are classified into 4 major genotypes with 2 distinct epidemiological profiles. In countries with poor environmental sanitation, HEV-1 and 2 (found exclusively in hu...
Virology
Published by
Bo Wang, Xiang-Jin Meng
Hepatitis E virus (HEV) is distinct from other hepatotropic viruses in that it is zoonotic and can infect across species barriers. HEV-1 and HEV-2 exclusively infect humans, whereas HEV-3 and HEV-4 ar...
Hepatitis E virus (HEV) is distinct from other hepatotropic viruses in that it is zoonotic and can infect across species barriers. HEV-1 and HEV-2 exclusively infect humans, whereas HEV-3 and HEV-4 ar...
One health
Published by
HAO WANG
Hepatitis E continues to be a significant global health challenge. In the EU/EEA region, the number of reported cases increased tenfold between 2005 and 2015. Sweden experienced a similar trend, with ...
Hepatitis E continues to be a significant global health challenge. In the EU/EEA region, the number of reported cases increased tenfold between 2005 and 2015. Sweden experienced a similar trend, with ...
Experimental model
Published by
Lin Wang
The rapid establishment of a viral infection animal model is valuable for pathogenesis studies and testing of vaccines and therapeutic agents. Common approaches may require inoculation of experimental...
The rapid establishment of a viral infection animal model is valuable for pathogenesis studies and testing of vaccines and therapeutic agents. Common approaches may require inoculation of experimental...
Public health
Published by
Nishan Katuwal
HEV is estimated to cause approximately 20 million new infections annually, leading to around 3.3 million symptomatic cases and 70,000 deaths. However, these figures may be underestimated due to limit...
HEV is estimated to cause approximately 20 million new infections annually, leading to around 3.3 million symptomatic cases and 70,000 deaths. However, these figures may be underestimated due to limit...
Pathology
Virus-host interaction
Published by
-
Hepatitis E virus (HEV) is a widespread zoonotic pathogen and the leading cause of acute viral hepatitis globally. Recent studies have revealed that HEV infection is associated with a broad spectrum o...
Hepatitis E virus (HEV) is a widespread zoonotic pathogen and the leading cause of acute viral hepatitis globally. Recent studies have revealed that HEV infection is associated with a broad spectrum o...
Hepatology
Public health
Vaccine
Virology
Published by
Susanne Dudman, Asma Aziz
We conducted a large phase 4, double-blind, cluster-randomised trial in 67 villages in Matlab, Bangladesh, and hereby share some of our results. Between 2017 and2021, 19 460 participants were randomis...
We conducted a large phase 4, double-blind, cluster-randomised trial in 67 villages in Matlab, Bangladesh, and hereby share some of our results. Between 2017 and2021, 19 460 participants were randomis...
0 - 8 of 94 items
EVENTS
2025-01-18
International Joint Meeting on Viral Infections of the Liver and the Heart (2025)
Day two of this symposium will place a special emphasis on Hepatitis E — a virus that, despite being the most common cause of viral hepatitis, offers a valuable opportunity for further research and understanding. Venue: Cantinerie Berlin Gustav-Meyer-Allee 25 13355 Berlin, Germany. Organisers: Prof. Dr. Jens Kurreck, Dr. rer. nat. Daniel Todt, Prof. Dr. med. Heiner Wedemeyer, More information: Medizinische Hochschule Hannover : International DFG/DZIF Joint Meeting on Viral Infections of the Liver and the Heart (mhh.de)
Day two of this symposium will place a special emphasis on Hepatitis E — a virus that, despite being the most common cause of viral hepatitis, offers a valuable opportunity for further research and understanding. Venue: Cantinerie Berlin Gustav-Meyer-Allee 25 13355 Berlin, Germany. Organisers: Prof. Dr. Jens Kurreck, Dr. rer. nat. Daniel Todt, Prof. Dr. med. Heiner Wedemeyer, More information: Medizinische Hochschule Hannover : International DFG/DZIF Joint Meeting on Viral Infections of the Liver and the Heart (mhh.de)
